Earnings Forecasts Show Mixed Results for Upcoming Reports

Earnings Forecasts Show Mixed Results as Several Companies Prepare to Report. Major players like Plug Power anticipate continued losses, while CPI Card Group forecasts substantial growth in earnings per share, revealing a diverse outlook amidst the upcoming earnings reports.

Date: 04-03-2025

AI Rating: 5

The report highlights earnings expectations for various companies prior to their earnings releases on March 4, 2025. Notably, key metrics such as earnings per share (EPS) are prominently featured, showcasing a mix of outlooks, particularly among companies within the S&P 500.

Earnings Per Share (EPS)

1. Plug Power, Inc. (PLUG): The consensus EPS forecast is $-0.23, a significant improvement from the previous year’s report of $-1.07, representing a decrease of -78.50%.

2. WAVE Life Sciences Ltd. (WVE): EPS is expected at $-0.17, showing a slight increase over last year's $-0.15, which reflects a positive growth trajectory of 13.33%.

3. Nayax Ltd. (NYAX): Forecasted EPS is $0.04, improving from the previous year's report of $-0.10, representing a sizeable decrease of -140.00%.

4. Olaplex Holdings, Inc. (OLPX): Expected EPS is $0.00, down from $0.03 the year prior, which indicates a decrease of -100.00%.

5. CPI Card Group Inc. (PMTS): Anticipated EPS rises to $0.55 compared to $0.23 last year, which marks a significant increase of 139.13%.

6. EVgo Inc. (EVGO): EPS forecast stands at $-0.15, up from $-0.12 last year, showing a 25.00% increase.

7. Esperion Therapeutics, Inc. (ESPR): The forecast indicates EPS of $-0.14, compared to $-0.50 a year ago, resulting in a decrease of -72.00%.

8. L.B. Foster Company (FSTR): EPS expectations are $0.28 versus $-0.04 previously, indicating a drastic downturn of -800.00%.

9. Y-mAbs Therapeutics, Inc. (YMAB): Expected EPS is $-0.13, reflecting an uptick from last year’s $-0.02, with a notable increase of 550.00%.

10. SOPHiA GENETICS SA (SOPH): The forecast for EPS of $-0.24 showcases a decrease from $-0.37 last year, decreasing by -35.14%.

11. Neuronetics, Inc. (STIM): The EPS forecast of $-0.25 demonstrates improvement over last year’s $-0.19, with a 31.58% increase.

12. Amylyx Pharmaceuticals, Inc. (AMLX): Forecast EPS is $-0.49, dropping significantly from last year’s $0.07, reflecting a decrease of -800.00%.

These earnings forecasts exhibit a highly varied landscape, with certain companies projected to experience substantial increases in EPS while others anticipate worsening conditions. This volatility can have significant impacts on stock prices and investor sentiment depending on the actual performances relative to these forecasts.

Stocks: PLUG WVE NYAX OLPX PMTS EVGO ESPR FSTR YMAB SOPH STIM AMLX